RHJA
GMED icon

Rice Hall James & Associates’s Globus Medical GMED Stock Holding History

Rice Hall James & Associates’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.91M Sell
62,166
-3,485
-5% -$296K 0.24% 102
2026
Q1 		$5.66M Sell
65,651
-759
-1% -$68.1K 0.32% 77
2025
Q4 		$5.8M Sell
66,410
-392
-0.6% -$29.8K 0.32% 76
2025
Q3 		$3.83M Sell
66,802
-333
-0.5% -$19.2K 0.21% 109
2025
Q2 		$3.96M Sell
67,135
-181
-0.3% -$11.7K 0.21% 99
2025
Q1 		$4.93M Sell
67,316
-259
-0.4% -$21.4K 0.29% 76
2024
Q4 		$5.59M Sell
67,575
-724
-1% -$57.1K 0.31% 73
2024
Q3 		$4.89M Sell
68,299
-875
-1% -$61.8K 0.26% 88
2024
Q2 		$4.74M Buy
69,174
+10,469
+18% +$625K 0.28% 77
2024
Q1 		$3.15M Buy
58,705
+12,315
+27% +$662K 0.18% 121
2023
Q4 		$2.47M Buy
+46,390
New +$2.26M 0.14% 153
2019
Q2 		– Sell
-311,342
Closed -$15.4M – 285
2019
Q1 		$15.4M Buy
311,342
+20,171
+7% +$912K 0.5% 75
2018
Q4 		$12.6M Buy
291,171
+5,076
+2% +$253K 0.46% 87
2018
Q3 		$16.2M Sell
286,095
-3,164
-1% -$167K 0.58% 68
2018
Q2 		$14.6M Sell
289,259
-15,306
-5% -$798K 0.53% 74
2018
Q1 		$15.2M Sell
304,565
-113,642
-27% -$5.34M 0.59% 67
2017
Q4 		$17.2M Sell
418,207
-160,509
-28% -$5.62M 0.68% 60
2017
Q3 		$17.2M Sell
578,716
-249,698
-30% -$7.62M 0.76% 55
2017
Q2 		$27.5M Buy
828,414
+888
+0.1% +$27.9K 1.19% 12
2017
Q1 		$24.5M Sell
827,526
-19,656
-2% -$536K 1.19% 9
2016
Q4 		$21M Sell
847,182
-17,537
-2% -$399K 1.06% 25
2016
Q3 		$19.5M Buy
864,719
+171,663
+25% +$4.03M 1.02% 29
2016
Q2 		$16.5M Buy
+693,056
New +$16.6M 0.95% 34

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Rice Hall James & Associates's GMED Position: Q2 2026 in Review

Rice Hall James & Associates reduced its Globus Medical (GMED) stake by 5.3% in Q2 2026, selling an estimated $296K and leaving 62,166 shares worth $4.91M. The position accounts for 0.24% of the portfolio, ranked #102.

Rice Hall James & Associates first reported a position in GMED in Q2 2016 and has held it in 23 quarters since. The position peaked at $27.5M in Q2 2017. 600 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Rice Hall James & Associates held 62,166 shares of Globus Medical worth $4.91M as of Q2 2026.
  • Rice Hall James & Associates sold 3,485 Globus Medical shares in Q2 2026, an estimated $296K.
  • Globus Medical made up 0.24% of Rice Hall James & Associates's portfolio in Q2 2026, its #102 holding.
  • Rice Hall James & Associates first reported a position in Globus Medical in Q2 2016 and has held it in 23 quarters since.
  • Rice Hall James & Associates's Globus Medical position peaked at $27.5M in Q2 2017.
  • 600 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Rice Hall James & Associates's 13F filing for Q2 2026, filed 7 Aug 2026.